CCI
DXCM icon

Columbus Circle Investors’s DexCom DXCM Stock Holding History

Columbus Circle Investors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-204,352
Closed -$21.1M – 148
2020
Q3 		$21.1M Sell
204,352
-155,520
-43% -$16.2M 0.92% 35
2020
Q2 		$36.5M Sell
359,872
-724,664
-67% -$64.8M 1.47% 18
2020
Q1 		$73M Sell
1,084,536
-329,900
-23% -$20.5M 4.02% 1
2019
Q4 		$77.3M Sell
1,414,436
-571,040
-29% -$27.1M 3.33% 1
2019
Q3 		$74.1M Sell
1,985,476
-297,348
-13% -$11.6M 2.72% 1
2019
Q2 		$85.5M Sell
2,282,824
-291,384
-11% -$9.16M 2.28% 2
2019
Q1 		$76.6M Sell
2,574,208
-202,248
-7% -$7.11M 1.95% 9
2018
Q4 		$83.2M Sell
2,776,456
-42,532
-2% -$1.35M 2.36% 4
2018
Q3 		$101M Buy
2,818,988
+689,032
+32% +$21.4M 2.01% 5
2018
Q2 		$50.6M Buy
2,129,956
+1,401,356
+192% +$29.7M 1.04% 26
2018
Q1 		$13.5M Buy
+728,600
New +$10.8M 0.27% 118
2017
Q2 		– Sell
-3,200,476
Closed -$67.8M – 258
2017
Q1 		$67.8M Sell
3,200,476
-588,812
-16% -$11.5M 0.95% 35
2016
Q4 		$56.6M Sell
3,789,288
-1,891,760
-33% -$33.5M 0.74% 51
2016
Q3 		$125M Sell
5,681,048
-1,104,204
-16% -$24.6M 1.34% 17
2016
Q2 		$135M Sell
6,785,252
-445,428
-6% -$7.58M 1.35% 19
2016
Q1 		$123M Buy
7,230,680
+609,292
+9% +$10.2M 1.09% 28
2015
Q4 		$136M Buy
6,621,388
+1,626,012
+33% +$33.8M 1.09% 27
2015
Q3 		$107M Buy
4,995,376
+1,367,740
+38% +$30.5M 0.88% 32
2015
Q2 		$72.5M Sell
3,627,636
-555,328
-13% -$9.75M 0.51% 55
2015
Q1 		$65.2M Buy
4,182,964
+1,095,468
+35% +$16.6M 0.44% 63
2014
Q4 		$42.5M Buy
3,087,496
+299,048
+11% +$3.66M 0.3% 81
2014
Q3 		$27.9M Sell
2,788,448
-267,048
-9% -$2.73M 0.2% 119
2014
Q2 		$30.3M Buy
3,055,496
+880,140
+40% +$7.8M 0.21% 116
2014
Q1 		$22.5M Buy
+2,175,356
New +$22.5M 0.15% 155
2013
Q4 		– Sell
-72,776
Closed -$513K – 308
2013
Q3 		$513K Buy
+72,776
New +$461K ﹤0.01% 284

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Columbus Circle Investors's DXCM Position: Q4 2020 in Review

Columbus Circle Investors sold out of DexCom (DXCM) in Q4 2020, closing a stake of 204,352 shares — an estimated $21.1M sold.

Columbus Circle Investors first reported a position in DXCM in Q3 2013 and held it in 25 quarters. The position peaked at $136M in Q4 2015. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Columbus Circle Investors reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Columbus Circle Investors sold 204,352 DexCom shares in Q4 2020, an estimated $21.1M.
  • Columbus Circle Investors first reported a position in DexCom in Q3 2013 and held it in 25 quarters.
  • Columbus Circle Investors's DexCom position peaked at $136M in Q4 2015.
  • 732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.